PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.1 pts more than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Johnson Pharmacare Ltd (formerly Sun and Shine Worldwide Ltd) reported audited results for FY25 with zero revenue from operations, mirroring a near-dormant business state. The company posted a net loss of Rs. 58.38 lakhs for FY25, wider than the Rs. 19.62 lakhs loss in FY24, with the Q4 FY25 loss alone at Rs. 51.32 lakhs. Cash flow from operations deteriorated sharply to a negative Rs. 190.89 lakhs versus a negative Rs. 4.54 lakhs last year. An exceptional item of Rs. 17.16 lakhs was booked towards an SEBI penalty. The auditor issued an unmodified (clean) opinion on the results.
For shareholders, the picture is concerning: no operating revenue, widening losses, and a steep drop in operating cash flow point to a company struggling for business traction. The shrinking other equity (from Rs. 175.30 to Rs. 116.91 lakhs) signals the capital base is being eroded each year, which could weigh on the stock price and investor confidence.